<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35415314</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2452-199X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>19</Volume>
            <PubDate>
              <Year>2023</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Bioactive materials</Title>
          <ISOAbbreviation>Bioact Mater</ISOAbbreviation>
        </Journal>
        <ArticleTitle>ROS-responsive 18β-glycyrrhetic acid-conjugated polymeric nanoparticles mediate neuroprotection in ischemic stroke through HMGB1 inhibition and microglia polarization regulation.</ArticleTitle>
        <Pagination>
          <StartPage>38</StartPage>
          <EndPage>49</EndPage>
          <MedlinePgn>38-49</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bioactmat.2022.03.040</ELocationID>
        <Abstract>
          <AbstractText>Ischemic stroke is an acute and serious cerebral vascular disease, which greatly affects people's health and brings huge economic burden to society. Microglia, as important innate immune components in central nervous system (CNS), are double-edged swords in the battle of nerve injury, considering their polarization between pro-inflammatory M1 or anti-inflammatory M2 phenotypes. High mobility group box 1 (HMGB1) is one of the potent pro-inflammatory mediators that promotes the M1 polarization of microglia. 18β-glycyrrhetinic acid (GA) is an effective intracellular inhibitor of HMGB1, but of poor water solubility and dose-dependent toxicity. To overcome the shortcomings of GA delivery and to improve the efficacy of cerebral ischemia therapy, herein, we designed reactive oxygen species (ROS) responsive polymer-drug conjugate nanoparticles (DGA) to manipulate microglia polarization by suppressing the translocation of nuclear HMGB1. DGA presented excellent therapeutic efficacy in stroke mice, as evidenced by the reduction of infarct volume, recovery of motor function, suppressed of M1 microglia activation and enhanced M2 activation, and induction of neurogenesis. Altogether, our work demonstrates a close association between HMGB1 and microglia polarization, suggesting potential strategies for coping with inflammatory microglia-related diseases.</AbstractText>
          <CopyrightInformation>© 2022 The Authors.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Jin</LastName>
            <ForeName>Lulu</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310027, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Zhixin</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310027, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hong</LastName>
            <ForeName>Liangjie</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310027, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qian</LastName>
            <ForeName>Zhefeng</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310027, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Fang</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>The MOE Frontier Science Center for Brain Research and Brain-Machine Integration, Zhejiang University School of Brain Science and Brain Medicine, Hangzhou, 310058, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mao</LastName>
            <ForeName>Zhengwei</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310027, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Bioact Mater</MedlineTA>
        <NlmUniqueID>101685294</NlmUniqueID>
        <ISSNLinking>2452-199X</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Drug delivery</Keyword>
        <Keyword MajorTopicYN="N">HMGB1</Keyword>
        <Keyword MajorTopicYN="N">Ischemic stroke</Keyword>
        <Keyword MajorTopicYN="N">M1/M2 phenotype</Keyword>
        <Keyword MajorTopicYN="N">Microglia</Keyword>
        <Keyword MajorTopicYN="N">Polymer-drug conjugates</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that no competing interest exists.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>13</Day>
          <Hour>5</Hour>
          <Minute>36</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35415314</ArticleId>
        <ArticleId IdType="pmc">PMC8980441</ArticleId>
        <ArticleId IdType="doi">10.1016/j.bioactmat.2022.03.040</ArticleId>
        <ArticleId IdType="pii">S2452-199X(22)00156-6</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Campbell B.C.V., De Silva D.A., Macleod M.R., Coutts S.B., Schwamm L.H., Davis S.M., Donnan G.A. Ischaemic stroke. Nat. Rev. Dis. Prim. 2019;5:71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31601801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tian X., Fan T.J., Zhao W.T., Abbas G., Han B., Zhang K., Li N., Liu N., Liang W.Y., Huang H., Chen W., Wang B., Xie Z.J. Recent advances in the development of nanomedicines for the treatment of ischemic stroke. Bioactive Materials. 2021;6:2854–2869.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7905263</ArticleId>
            <ArticleId IdType="pubmed">33718667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen W., Jiang L.F., Hu Y.Q., Fang G., Yang B.L., Li J.H., Liang N., Wu L., Hussain Z. Nanomedicines, an emerging therapeutic regimen for treatment of ischemic cerebral stroke: a review. J. Contr. Release. 2021;340:342–360.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34695522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang H.J., Xu X., Guan X., Shen S.Y., Huang X.C., Kai G.Y., Zhao S.Y., Ruan W.C., Zhang L.Y., Pang T., Mo R. Liposomal 9-aminoacridine for treatment of ischemic stroke: from drug discovery to drug delivery. Nano Lett. 2020;20:1542–1551.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32039606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang L.-H., Chuang E.-Y., Cheng T.-M., Lin C., Shih C.-M., Wu A.T., Jheng P.-R., Lu H.-Y., Shih C.-C., Mi F.-L. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent. Acta Biomater. 2021;134:686–701.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34358695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ding Y., Sun Z.Q., Gao Y., Zhang S.T., Yang C.X., Qian Z.F., Jin L.L., Zhang J.J., Zeng C., Mao Z.W., Wang W.L. Plasmon-driven catalytic chemotherapy augments cancer immunotherapy through induction of immunogenic cell death and blockage of Ido pathway. Adv. Mater. 2021;33:14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34278622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi K.B., Tian D.C., Li Z.L.G., Ducruet A.F., Lawton M.T., Shi F.D. Global brain inflammation in stroke. Lancet Neurol. 2019;18:1058–1066.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31296369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Szalay G., Martinecz B., Lenart N., Kornyei Z., Orsolits B., Judak L., Csaszar E., Fekete R., West B.L., Katona G., Rozsa B., Denes A. Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke. Nat. Commun. 2016;7:13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4857403</ArticleId>
            <ArticleId IdType="pubmed">27139776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li M.S., Li Z.G., Ren H.L., Jin W.N., Wood K., Liu Q., Sheth K.N., Shi F.D. Colony stimulating factor 1 receptor inhibition eliminates microglia and attenuates brain injury after intracerebral hemorrhage. J. Cerebr. Blood Flow Metabol. 2017;37:2383–2395.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5482387</ArticleId>
            <ArticleId IdType="pubmed">27596835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu X.M., Leak R.K., Shi Y.J., Suenaga J., Gao Y.Q., Zheng P., Chen J. Microglial and macrophage polarization -new prospects for brain repair. Nat. Rev. Neurol. 2015;11:56–64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4395497</ArticleId>
            <ArticleId IdType="pubmed">25385337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao L., Wei F., Zhou Y.H., Anderson G.J., Frazer D.M., Lim Y.C., Liu T.Q., Xiao Y. Dihydrolipoic acid-gold nanoclusters regulate microglial polarization and have the potential to alter neurogenesis. Nano Lett. 2020;20:478–495.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31789044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao Z.S., Zhang C.J., Xia N., Tian H., Li D.Y., Lin J.Q., Mei X.F., Wu C. Berberine-loaded M2 macrophage-derived exosomes for spinal cord injury therapy. Acta Biomater. 2021;126:211–223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33722788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wofford K.L., Singh B.S., Cullen D.K., Spiller K.L. Biomaterial-mediated reprogramming of monocytes via microparticle phagocytosis for sustained modulation of macrophage phenotype. Acta Biomater. 2020;101:237–248.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6960335</ArticleId>
            <ArticleId IdType="pubmed">31731024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu Y.F., Li C., Chen Q.J., Liu P.X., Guo Q., Zhang Y., Chen X.L., Zhang Y.J., Zhou W.X., Liang D.H., Zhang Y.W., Sun T., Lu W.G., Jiang C. Microthrombus-targeting micelles for neurovascular remodeling and enhanced microcirculatory perfusion in acute ischemic stroke. Adv. Mater. 2019;31:12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30957932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao X.H., Li S., Ding F., Liu X.L., Wu Y.J., Li J., Feng J., Zhu X.Y., Zhang C. A virus-mimicking nucleic acid nanogel reprograms microglia and macrophages for glioblastoma therapy. Adv. Mater. 2021;33:9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33501743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng L.S., Dou C.R., Xia Y.G., Li B.H., Zhao M.Y., Yu P., Zheng Y.Y., El-Toni A.M., Atta N.F., Galal A., Cheng Y.S., Cai X.J., Wang Y., Zhang F. Neutrophil-like cell-membrane-coated nanozyme therapy for ischemic brain damage and long-term neurological functional recovery. ACS Nano. 2021;15:2263–2280.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33426885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luo Y.L., Zheng X.W., Yuan P.Q., Ye X.Y., Ma L. Light-induced dynamic RGD pattern for sequential modulation of macrophage phenotypes. Bioactive Materials. 2021;6:4065–4072.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8089772</ArticleId>
            <ArticleId IdType="pubmed">33997493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang R., Chen R.C., Zhang Q.H., Hou W., Wu S., Cao L.Z., Huang J., Yu Y., Fan X.G., Yan Z.W., Sun X.F., Wang H.C., Wang Q.D., Tsung A., Billiar T.R., Zeh H.J., Lotze M.T., Tang D.L. HMGB1 in health and disease. Mol. Aspect. Med. 2014;40:1–116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4254084</ArticleId>
            <ArticleId IdType="pubmed">25010388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Avgousti D.C., Herrmann C., Kulej K., Pancholi N.J., Sekulic N., Petrescu J., Molden R.C., Blumenthal D., Paris A.J., Reyes E.D., Ostapchuk P., Hearing P., Seeholzer S.H., Worthen G.S., Black B.E., Garcia B.A., Weitzman M.D. A core viral protein binds host nucleosomes to sequester immune danger signals. Nature. 2016;535:173–177.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4950998</ArticleId>
            <ArticleId IdType="pubmed">27362237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Das S., Mishra K.P., Chanda S., Ganju L., Singh S.B. CXCR7: a key neuroprotective molecule against alarmin HMGB1 mediated CNS pathophysiology and subsequent memory impairment. Brain Behav. Immun. 2019;82:319–337.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31505255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao T.L., Chen Z., Chen H., Yuan H., Wang Y.N., Peng X., Wei C., Yang J.X., Xu C.Q. Inhibition of HMGB1 mediates neuroprotection of traumatic brain injury by modulating the microglia/macrophage polarization. Biochem. Biophys. Res. Commun. 2018;497:430–436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29448108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan H., Tang H.B., Chen Z., Wang H.Q., Zhang L., Jiang Y., Li T., Yang C.F., Wang X.Y., Li X., Wu S.X., Zhang G.L. Inhibiting HMGB1-RAGE axis prevents pro-inflammatory macrophages/microglia polarization and affords neuroprotection after spinal cord injury. J. Neuroinflammation. 2020;17:17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7547440</ArticleId>
            <ArticleId IdType="pubmed">33036632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liesz A., Dalpke A., Mracsko E., Antoine D.J., Roth S., Zhou W., Yang H., Na S.Y., Akhisaroglu M., Fleming T., Eigenbrod T., Nawroth P.P., Tracey K.J., Veltkamp R. DAMP signaling is a key pathway inducing immune modulation after brain injury. J. Neurosci. 2015;35:583–598.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4293412</ArticleId>
            <ArticleId IdType="pubmed">25589753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agalave N.M., Rudjito R., Farinotti A.B., Khoonsari P.E., Sandor K., Nomura Y., Szabo-Pardi T.A., Urbina C.M., Palada V., Price T.J., Harris H.E., Burton M.D., Kultima K., Svensson C.I. Sex-dependent role of microglia in disulfide high mobility group box 1 protein-mediated mechanical hypersensitivity. Pain. 2021;162:446–458.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7808363</ArticleId>
            <ArticleId IdType="pubmed">32773600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao H.M., Zhou H., Zhang F., Wilson B.C., Kam W., Hong J.S. HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration. J. Neurosci. 2011;31:1081–1092.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3046932</ArticleId>
            <ArticleId IdType="pubmed">21248133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>VanPatten S., Al-Abed Y. High mobility group box-1 (HMGb1): current wisdom and advancement as a potential drug target. J. Med. Chem. 2018;61:5093–5107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29268019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu X.D., Zhang L.Y., Gurley E., Studer E., Shang J., Wang T., Wang C.F., Yan M., Jiang Z.Z., Hylemon P.B., Sanyal A.J., Pandak W.M., Zhou H.P. Prevention of free fatty acid-induced hepatic lipotoxicity by 18 beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways. Hepatology. 2008;47:1905–1915.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18452148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paudel Y.N., Angelopoulou E., Semple B., Piperi C., Othman I., Shaikh M.F. Potential neuroprotective effect of the HMGB1 inhibitor glycyrrhizin in neurological disorders. ACS Chem. Neurosci. 2020;11:485–500.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31972087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang W.P., Lei Y.Y., Sui H., Zhang W.P., Zhu R.Y., Feng J., Wang H. Fabrication and evaluation of nanoparticle-assembled BSA microparticles for enhanced liver delivery of glycyrrhetinic acid. Artif. Cells Nanomed. Biotechnol. 2017;45:740–747.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27267996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang M., Cheng H.Y., Gong Z.N., Zhang J.T., Liu X., Wang B.B., Ban L.N., Zeng Y., Zhu Z.H. Fabrication of chitosan-18 beta-glycyrrhetinic acid modified titanium implants with nanorod arrays for suppression of osteosarcoma growth and improvement of osteoblasts activity. Adv. Funct. Mater. 2017;27:13.</Citation>
        </Reference>
        <Reference>
          <Citation>Ravanfar P., Namazi G., Atigh M., Zafarmand S., Hamedi A., Salehi A., Izadi S., Borhani-Haghighi A. Efficacy of whole extract of licorice in neurological improvement of patients after acute ischemic stroke. J. Herb. Med. 2016;6:12–17.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhao X.L., Jin L.L., Zhu Z.X., Lu H.H., Shi H.F., Zhong Q., Oliveira J.M., Reis R.L., Gao C.Y., Mao Z.W. Conotoxin loaded dextran microgel particles alleviate effects of spinal cord injury by inhibiting neuronal excitotoxicity. Appl. Mater. Today. 2021;23:10.</Citation>
        </Reference>
        <Reference>
          <Citation>Ding Y., Xu H., Xu C., Tong Z.R., Zhang S.T., Bai Y., Chen Y.N., Xu Q.H., Zhou L.Z., Ding H., Sun Z.Q., Yan S., Mao Z.W., Wang W.L. A nanomedicine fabricated from gold nanoparticles-decorated metal-organic framework for cascade chemo/chemodynamic cancer therapy. Adv. Sci. 2020;7:10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7507500</ArticleId>
            <ArticleId IdType="pubmed">32995124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Y.W., Shen W.L., Tang C.Q., Huang J.Y., Fan C.M., Yin Z., Hu Y.J., Chen W.S., Ouyang H.W., Zhou Y.T., Mao Z.W., Chen X. Targeted pathological collagen delivery of sustained-release rapamycin to prevent heterotopic ossification. Sci. Adv. 2020;6:13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7239699</ArticleId>
            <ArticleId IdType="pubmed">32494667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee J.-R., Park B.-W., Park J.-H., Lim S., Kwon S.P., Hwang J.-W., Kim H., Park H.-J., Kim B.-S. Local delivery of a senolytic drug in ischemia and reperfusion-injured heart attenuates cardiac remodeling and restores impaired cardiac function. Acta Biomater. 2021:520–533.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34454081</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu Y., Li J., Wang G.J. In vitro and in vivo evaluation of mPEG-PLA modified liposomes loaded glycyrrhetinic acid. Int. J. Pharm. 2008;356:274–281.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18304766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosenkrans Z.T., Ferreira C.A., Ni D.L., Cai W.B. Internally responsive nanomaterials for activatable multimodal imaging of cancer. Adv. Healthcare Mater. 2021;10:18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7855763</ArticleId>
            <ArticleId IdType="pubmed">32691969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li G.T., Sun B.J., Li Y.Q., Luo C., He Z.G., Sun J. Small-molecule prodrug nanoassemblies: an emerging nanoplatform for anticancer drug delivery. Small. 2021:29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34342126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun T., Dasgupta A., Zhao Z.M., Nurunnabi M., Mitragotri S. Physical triggering strategies for drug delivery. Adv. Drug Deliv. Rev. 2020;158:36–62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32589905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tian B.R., Liu Y.M., Liu J.Y. Smart stimuli-responsive drug delivery systems based on cyclodextrin: a review. Carbohydr. Polym. 2021;251:14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33142550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jaglal Y., Osman N., Omolo C.A., Mocktar C., Devnarain N., Govender T. Formulation of pH-responsive lipid-polymer hybrid nanoparticles for co-delivery and enhancement of the antibacterial activity of vancomycin and 18 beta-glycyrrhetinic acid. J. Drug Deliv. Sci. Technol. 2021;64:14.</Citation>
        </Reference>
        <Reference>
          <Citation>Ren Z.G., Sun S.C., Sun R.R., Cui G.Y., Hong L.J., Rao B.C., Li A., Yu Z.J., Kan Q.C., Mao Z.W. A metal-polyphenol-coordinated nanomedicine for synergistic cascade cancer chemotherapy and chemodynamic therapy. Adv. Mater. 2020;32:10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31834662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao T.J., Wu W., Sui L.H., Huang Q., Nan Y.Y., Liu J.H., Ai K.L. Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries. Bioactive Materials. 2022;7:47–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8377441</ArticleId>
            <ArticleId IdType="pubmed">34466716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu L.Q., Cao Z.Y., Ma L.L., Liu Z.Q., Liao G.C., Wang J.X., Shen S., Li D.D., Yang X.Z. The potentiated checkpoint blockade immunotherapy by ROS-responsive nanocarrier-mediated cascade chemo-photodynamic therapy. Biomaterials. 2019;223:10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31520886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lv W., Xu J.P., Wang X.Q., Li X.R., Xu Q.W., Xin H.L. Bioengineered boronic ester modified dextran polymer nanoparticles as reactive oxygen species responsive nanocarrier for ischemic stroke treatment. ACS Nano. 2018;12:5417–5426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29869497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang R., Liu R., Liu C., Pan L., Qi Y., Cheng J., Guo J., Jia Y., Ding J., Zhang J., Hu H. A pH/ROS dual-responsive and targeting nanotherapy for vascular inflammatory diseases. Biomaterials. 2020;230</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31740099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stubelius A., Lee S., Almutairi A. The chemistry of boronic acids in nanomaterials for drug delivery. Acc. Chem. Res. 2019;52:3108–3119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31599160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siewert C., Haas H., Nawroth T., Ziller A., Nogueira S.S., Schroer M.A., Blanchet C.E., Svergun D.I., Radulescu A., Bates F., Huesemann Y., Radsak M.P., Sahin U., Langguth P. Investigation of charge ratio variation in mRNA - DEAE-dextran polyplex delivery systems. Biomaterials. 2019;192:612–620.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30502967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong Z., Wang J.C., Ren Z., Dong G.B. Ortho C-H acylation of aryl iodides by palladium/norbornene catalysis. Angew. Chem. Int. Ed. 2015;54:12664–12668.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26333071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee S., Stubelius A., Hamelmann N., Tran V., Almutairi A. Inflammation-responsive drug-conjugated dextran nanoparticles enhance anti-inflammatory drug efficacy. ACS Appl. Mater. Interfaces. 2018;10:40378–40387.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7170936</ArticleId>
            <ArticleId IdType="pubmed">30067018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hinkes S.P.A., Klein C.D.P. Virtues of volatility: a facile transesterification approach to boronic acids. Org. Lett. 2019;21:3048–3052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31012586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Awino J.K., Gunasekara R.W., Zhao Y. Selective recognition of d-aldohexoses in water by boronic acid-functionalized, molecularly imprinted cross-linked micelles. J. Am. Chem. Soc. 2016;138:9759–9762.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4982515</ArticleId>
            <ArticleId IdType="pubmed">27442012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mei T., Kim A., Vong L.B., Marushima A., Puentes S., Matsumaru Y., Matsumura A., Nagasaki Y. Encapsulation of tissue plasminogen activator in pH-sensitive self-assembled antioxidant nanoparticles for ischemic stroke treatment - synergistic effect of thrombolysis and antioxidant. Biomaterials. 2019;215:12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31181394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shahi M., Abedelahi A., Mohammadnejad D., Rahbarghazi R., Rasta S.H., Karimipour M. Exact location of sensorimotor cortex injury after photochemical modulation; evidence of stroke based on stereological and morphometric studies in mice. Laser Med. Sci. 2021;36:91–98.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32297252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peviani M., Palmiero U.C., Cecere F., Milazzo R., Moscatelli D., Biffi A. Biodegradable polymeric nanoparticles administered in the cerebrospinal fluid: brain biodistribution, preferential internalization in microglia and implications for cell-selective drug release. Biomaterials. 2019;209:25–40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31026609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grossman K.J., Stein D.G. Does endogenous progesterone promote recovery of chronic sensorimotor deficits following contusion to the forelimb representation of the sensorimotor cortex? Behav. Brain Res. 2000;116:141–148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11080545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roome R.B., Vanderluit J.L. Paw-dragging: a novel, sensitive analysis of the mouse cylinder test. Jove-J. Visualized Exp. 2015;98</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4541598</ArticleId>
            <ArticleId IdType="pubmed">25993447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu J.P., Wang X.Q., Yin H.Y., Cao X., Hu Q.Y., Lv W., Xu Q.W., Gu Z., Xin H.L. Sequentially site-specific delivery of thrombolytics and neuroprotectant for enhanced treatment of ischemic stroke. ACS Nano. 2019;13:8577–8588.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31339295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li C.W., Bian Y.Q., Feng Y., Tang F., Wang L., Hoi M.P.M., Ma D., Zhao C., Lee S.M.Y. Neuroprotective effects of BHDPC, a novel neuroprotectant, on experimental stroke by modulating microglia polarization. ACS Chem. Neurosci. 2019;10:2434–2449.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30839193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu B., Wu R.L., Gong S., Xiao H., Thayumanavan S. In situ formation of polymeric nanoassemblies using an efficient reversible click reaction. Angew. Chem. Int. Ed. 2020;59:15135–15140.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7666047</ArticleId>
            <ArticleId IdType="pubmed">32410309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guan Y., Niu H., Liu Z.T., Dang Y., Shen J., Zayed M., Ma L., Guan J.J. Sustained oxygenation accelerates diabetic wound healing by promoting epithelialization and angiogenesis and decreasing inflammation. Sci. Adv. 2021;7:14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8397271</ArticleId>
            <ArticleId IdType="pubmed">34452918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J., Liu L.G., Jiao W.Q., Yang H., Liu J., Liu D.H. Phenylboronic acid-conjugated chitosan nanoparticles for high loading and efficient delivery of curcumin. Carbohydr. Polym. 2021;256:9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33483024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu Y., Wang Y., Long L.Y., Hu C., Kong Q.Q., Wang Y.B. A spatiotemporal release platform based on pH/ROS stimuli-responsive hydrogel in wound repairing. J. Contr. Release. 2022;341:147–165.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34813880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng H., Jiang Z.J., Sun C.K., Wang Z., Han G.C., Chen X., Li T.Y., Fan Z.C., Zhang F., Yang X.Y., Lv L.Y., Zhang H.Q., Zhou J.P., Ding Y. Protein stabilized polymeric nanoparticles inspired relay drug delivery for tackling post-chemotherapeutic metastasis. Chem. Eng. J. 2022;427:16.</Citation>
        </Reference>
        <Reference>
          <Citation>Shi W., Hass B., Kuss M.A., Zhang H.P., Ryu S.J., Zhang D.Z., Li T.S., Li Y.L., Duan B. Fabrication of versatile dynamic hyaluronic acid-based hydrogels. Carbohydr. Polym. 2020;233:12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32059877</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salter M.W., Stevens B. Microglia emerge as central players in brain disease. Nat. Med. 2017;23:1018–1027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28886007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siddiqui T.A., Lively S., Schlichter L.C. Complex molecular and functional outcomes of single versus sequential cytokine stimulation of rat microglia. J. Neuroinflammation. 2016;13:66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4806433</ArticleId>
            <ArticleId IdType="pubmed">27009332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sani D., Khatab N.I.O., Kirby B.P., Yong A., Hasan S., Basri H., Stanslas J. A standardised Andrographis paniculata Burm. Nees aqueous extract prevents Lipopolysaccharide-induced cognitive deficits through suppression of inflammatory cytokines and oxidative stress mediators. J. Adv. Res. 2019;16:87–97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6412812</ArticleId>
            <ArticleId IdType="pubmed">30899592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tyrtyshnaia A.A., Lysenko L.V., Madamba F., Manzhulo I.V., Khotimchenko M.Y., Kleschevnikov A.M. Acute neuroinflammation provokes intracellular acidification in mouse hippocampus. J. Neuroinflammation. 2016;13:11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5094044</ArticleId>
            <ArticleId IdType="pubmed">27809864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cho W., Koo J.Y., Park Y., Oh K., Lee S., Song J.S., Bae M.A., Lim D., Lee D.S., Park S.B. Treatment of sepsis pathogenesis with high mobility group box protein 1-regulating anti-inflammatory agents. J. Med. Chem. 2017;60:170–179.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28001381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y., Long L.Y., Zhang F.J., Hu X.F., Zhang J.Y., Hu C., Wang Y.B., Xu J.G. Microneedle-mediated vascular endothelial growth factor delivery promotes angiogenesis and functional recovery after stroke. J. Contr. Release. 2021;338:610–622.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34481025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jackman K., Iadecola C. Neurovascular regulation in the ischemic brain. Antioxidants Redox Signal. 2015;22:149–160.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4281847</ArticleId>
            <ArticleId IdType="pubmed">24328757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jia J.Q., Yang L.X., Chen Y., Zheng L.L., Chen Y.T., Xu Y., Zhang M.J. The role of microglial phagocytosis in ischemic stroke. Front. Immunol. 2022;12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8784388</ArticleId>
            <ArticleId IdType="pubmed">35082781</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
